• HC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

    Source: Buzz FX / 20 Dec 2024 11:36:12   America/New_York


    HC Wainwright Reaffirms Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Written by MarketBeat December 20, 2024 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "buy" rating
    Read more...
Share on,